<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03819075</url>
  </required_header>
  <id_info>
    <org_study_id>26/CE-IUCS/2018</org_study_id>
    <nct_id>NCT03819075</nct_id>
  </id_info>
  <brief_title>Combined Er:YAG And Nd:YAG Laser Protocol For Treatment Of Peri-Implantitis</brief_title>
  <official_title>An Evaluation Of Effectiveness Of A Combined Er:YAG And Nd:YAG Laser Protocol For Treatment Of Peri-Implantitis: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luis Monteiro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cooperativa de Ensino Superior, Politécnico e Universitário</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A laser treatment for periimplantitis using two different wavelengths (Er:YAG and Nd:YAG)
      will be compared to standard treatment in a randomized clinical trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The general aim of this study is to evaluate the clinical outcome of the treatment of
      peri-implantitis using a combination of a Er:YAG and Nd:YAG laser protocol or using a
      conventional mechanical treatment in patients with a diagnosis of peri-implantitis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 3, 2018</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two groups; laser and control</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Clinical measurements will be performed by an evaluator unaware of group assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants with treatment success</measure>
    <time_frame>6 months</time_frame>
    <description>Treatment success defined as implant survival with the absence of peri-implant probing depths (PD) greater than 5 mm with concomitant bleeding/suppuration and absence of progression of peri-implant bone loss.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plaque index</measure>
    <time_frame>1 month</time_frame>
    <description>(PI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque index</measure>
    <time_frame>3 months</time_frame>
    <description>(PI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque index</measure>
    <time_frame>6 months</time_frame>
    <description>(PI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plaque index</measure>
    <time_frame>12 months</time_frame>
    <description>(PI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>1 month</time_frame>
    <description>(BOP) evaluated as present if bleeding was evident within 30 s after probing, or absent, if no bleeding was noticed within 30 s after probing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>3 months</time_frame>
    <description>evaluated as present if bleeding was evident within 30 s after probing, or absent, if no bleeding was noticed within 30 s after probing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>6 months</time_frame>
    <description>evaluated as present if bleeding was evident within 30 s after probing, or absent, if no bleeding was noticed within 30 s after probing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing</measure>
    <time_frame>12 months</time_frame>
    <description>evaluated as present if bleeding was evident within 30 s after probing, or absent, if no bleeding was noticed within 30 s after probing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing depth</measure>
    <time_frame>1 month</time_frame>
    <description>measured from the mucosal margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing depth</measure>
    <time_frame>3 months</time_frame>
    <description>measured from the mucosal margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing depth</measure>
    <time_frame>6 months</time_frame>
    <description>measured from the mucosal margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing depth</measure>
    <time_frame>12 months</time_frame>
    <description>measured from the mucosal margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mucosal recession</measure>
    <time_frame>1 month</time_frame>
    <description>measured from the mucosal margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mucosal recession</measure>
    <time_frame>3 months</time_frame>
    <description>measured from the mucosal margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mucosal recession</measure>
    <time_frame>6 months</time_frame>
    <description>measured from the mucosal margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mucosal recession</measure>
    <time_frame>12 months</time_frame>
    <description>measured from the mucosal margin to the bottom of the pocket.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level gain</measure>
    <time_frame>1 month</time_frame>
    <description>Difference in clinical attachment level at baseline and follow up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level gain</measure>
    <time_frame>3 months</time_frame>
    <description>Difference in clinical attachment level at baseline and follow up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level gain</measure>
    <time_frame>6 months</time_frame>
    <description>Difference in clinical attachment level at baseline and follow up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level gain</measure>
    <time_frame>12 months</time_frame>
    <description>Difference in clinical attachment level at baseline and follow up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>0 months</time_frame>
    <description>Oral Health Impact Profile-14 on the scale from 0 to 56 with higher scores indicating a poorer oral health-related quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>1 month</time_frame>
    <description>Oral Health Impact Profile-14 on the scale from 0 to 56 with higher scores indicating a poorer oral health-related quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>3 months</time_frame>
    <description>Oral Health Impact Profile-14 on the scale from 0 to 56 with higher scores indicating a poorer oral health-related quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>6 months</time_frame>
    <description>Oral Health Impact Profile-14 on the scale from 0 to 56 with higher scores indicating a poorer oral health-related quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>Oral Health Impact Profile-14 on the scale from 0 to 56 with higher scores indicating a poorer oral health-related quality of life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Peri-Implantitis</condition>
  <arm_group>
    <arm_group_label>Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For the laser group we will use a Lightwalker Laser (Fotona) with a Er:YAG 2940 nm and Nd:YAG 1064 nm wavelengths units.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard periimplantitis treatment will be conducted in the control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lightwalker Laser (Fotona)</intervention_name>
    <description>For the laser group we will use a Lightwalker Laser (Fotona) with a Er:YAG 2940 nm and Nd:YAG 1064 nm wavelengths units. The laser protocol will follow the instructions of the manufacturer (TwinLight protocol) and consists of degranulation of necrotic soft tissue and bone, implant surface disinfection and creating spot bleeding in bone with Er:YAG and deep disinfection and biomodulation with Nd:YAG.</description>
    <arm_group_label>Laser</arm_group_label>
    <other_name>TwinLight periimplantitis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard</intervention_name>
    <description>Granulation tissue elimination, mechanical instrumentation of the implant surface and curettage of intraosseous or supracrestally bone defects will be accomplished using plastic curets, under irrigation with sterile saline solution. Cotton pellets soaked in sterile saline solution will be use to clean debris and remains of removed tissue.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least one implant with peri-implantitis

          -  no serious mobility of the implants

          -  written informed consent of the voluntary participant in the study

          -  availability of participant for control visits for a follow-up of at least 12 months
             without interruptions

        Exclusion Criteria:

          -  serious systematic disease

          -  pregnancy

          -  current use of photosensitive drugs, bisphosphonate medication or antibiotics

          -  patients who do not want to follow post treatment recommendation of oral hygiene and
             follow-up visits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis Monteiro, DMD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Universitário de Ciências da Saude, CESPU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luis Monteiro, DMD, PhD</last_name>
    <phone>+351 919120226</phone>
    <email>luis.monteiro@iucs.cespu.pt</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto Universitário de Ciências da Saude, CESPU</name>
      <address>
        <city>Porto</city>
        <zip>4585-116</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Monteiro</last_name>
      <phone>+351 919120226</phone>
      <email>luis.monteiro@iucs.cespu.pt</email>
    </contact>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 25, 2019</study_first_submitted>
  <study_first_submitted_qc>January 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2019</study_first_posted>
  <last_update_submitted>January 28, 2019</last_update_submitted>
  <last_update_submitted_qc>January 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cooperativa de Ensino Superior, Politécnico e Universitário</investigator_affiliation>
    <investigator_full_name>Luis Monteiro</investigator_full_name>
    <investigator_title>DMD, Phd, Auxiliar Professor at the IUCS in Periodontal Surgical Clinic, Oral Pathology and Biopathology</investigator_title>
  </responsible_party>
  <keyword>laser</keyword>
  <keyword>Er:YAG</keyword>
  <keyword>Nd:YAG</keyword>
  <keyword>periimplantitis</keyword>
  <keyword>randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peri-Implantitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

